Good morning :)
Place Order
Add to Watchlist

Amrutanjan Health Care Ltd

AMRUTANJAN

Amrutanjan Health Care Ltd

AMRUTANJAN
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,195 cr, stock is ranked 1,060
Moderate RiskStock is 2.28x as volatile as Nifty
752.400.00% (+0.00)
752.400.00% (+0.00)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,195 cr, stock is ranked 1,060
Moderate RiskStock is 2.28x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,195 cr, stock is ranked 1,060
Moderate RiskStock is 2.28x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
48.827.550.48%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Amrutanjan Health Care Limited is engaged in offering ayurvedic balm for headaches, cold and cough. The Company operates through three segments: over-the-counter (OTC) products, beverages and others.

Investor Presentation

View older 

Aug 4, 2023

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 10.94%, vs industry avg of 8.96%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.11% to 0.12%

Lower than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 12.89%, vs industry avg of 15.15%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue190.11214.14227.88260.36269.80344.16421.22394.18437.58437.58
Raw Materialssubtract64.8685.6994.01122.16124.05135.18185.96183.71369.42369.42
Power & Fuel Costsubtract1.631.661.701.872.021.762.663.06
Employee Costsubtract28.0129.6733.8533.3639.3641.7048.2348.81
Selling & Administrative Expensessubtract54.9154.3353.1459.9661.4564.7284.6888.57
Operating & Other expensessubtract3.426.699.104.953.7714.644.7410.95
Depreciation/Amortizationsubtract2.522.052.913.164.363.673.805.216.066.05
Interest & Other Itemssubtract0.200.250.310.200.340.590.580.220.160.15
Taxes & Other Itemssubtract12.1511.9912.9110.179.3720.7123.3913.8116.9716.98
EPS7.677.466.838.398.5820.9322.9813.6315.5015.39
DPS1.931.931.532.152.104.204.604.603.604.60
Payout ratio0.250.260.220.260.240.200.200.340.230.30

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2022

Annual report

PDF

Investor Presentation

May 25PDF
Feb 12PDF
Nov 9PDF
Aug 14PDF
FY 2023

Annual report

PDF

Investor Presentation

Jun 1PDF
Feb 14PDF
Nov 5PDF
+2 more
FY 2024

Annual Report Pending

Investor Presentation

Aug 4PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Amrutanjan Health Care Ltd48.837.550.48%
Sun Pharmaceutical Industries Ltd39.525.640.86%
Cipla Ltd29.515.130.86%
Zydus Lifesciences Ltd30.646.010.26%

Price Comparison

Compare AMRUTANJAN with any stock or ETF
Compare AMRUTANJAN with any stock or ETF
AMRUTANJAN
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Decreased Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has decreased by 1.02%

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding50.59%6.79%0.50%1.38%40.74%

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Shareholding History

Dec '22MarJunSepDec '23Mar0.76%0.68%0.70%0.75%0.80%1.38%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 2 Mutual Funds holding Amrutanjan Health Care Ltd



Funds (Top 2)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
DSP Small Cap Fund - Growth - Direct Plan

Growth
5.0047%0.72%0.02%60/80 (-4)
Sundaram Small Cap Fund - Growth - Direct Plan

Growth
1.5433%1.09%0.07%47/91 (-20)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Trend In Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

AMRUTANJAN has shown inconsistent dividend trend over the last 5 years

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.48%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹4.79 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateFeb 20, 2024

Interim 2
Interim 2 | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Feb 20, 2024

Cash Dividend

Ex DateEx DateNov 23, 2023

Interim 1
Interim 1 | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Nov 23, 2023

Cash Dividend

Ex DateEx DateSep 14, 2023

Final
Final | Div/Share: ₹2.60

Dividend/Share

2.60

Ex DateEx Date

Sep 14, 2023

Cash Dividend

Ex DateEx DateFeb 24, 2023

Interim 2
Interim 2 | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Feb 24, 2023

Cash Dividend

Ex DateEx DateNov 14, 2022

Interim 1
Interim 1 | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Nov 14, 2022